Background: Alterations in the expressions of ETS variant-6 (ETV6) and Nuclear Factor Erythroid 2 (NFE2) may occur as part of cellular response to phenyl-hydrazine administration and the need to replenish RBCs. Understanding the relationship between phenyl-hydrazine-induced damage, erythropoiesis, and transcriptional regulation mediated by ETV6 and NFE2 provides valuable insights into the mechanisms underlying anaemia. Therefore, this study aimed to determine the effect of bi-herbal formula of Picralima nitida and Cymbopogon citratus aqueous leaf extracts on ETV6 and NFE2 gene expressions in phenyl-hydrazine induced anaemia in albino Wistar rats. Methods: A total of 60 adult male albino Wistar rats were divided into six groups; A, B, C, D, E and F representing control, phenyl-hydrazine group, ferrous sulphate group, phenyl-hydrazine+ 100mg/kg bi-herbal formulation of Picralima nitida and Cymbopogon citratus, phenyl-hydrazine+ 200mg/kg bi-herbal formulation of Picralima nitida and Cymbopogon citratus and phenyl-hydrazine+ 400mg/kg bi-herbal formulation of Picralima nitida and Cymbopogon citratus respectively. Messenger RNA (mRNA) ETV6 and NFE2 were determined using polymerase chain reaction. Results: mRNA expression of ETV6 of group B was higher when compared to group A (p<0.05). Groups C and D showed statistically significant higher expression of ETV6 when compared to group A and B (p=0.001). There was a significant decrease in the mRNA expression of NFE2 of group B when compared to group A (p=0.001). Groups E and F showed statistically significant lower expressions of NFE2 when compared to groups A and B (p=0.001). Conclusion: Phenyl-hydrazine and bi-herbal formulation of Picralima nitida and Cymbopogon citratus caused positive alterations in ETV6 and NFE2.
No takes yet. Share an insight, caveat, or question.
Obazelu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: